D.E. Shaw & Co’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-17,153
| Closed | -$77.7K | – | 4564 |
|
|
2025
Q3 | $77.7K | Sell |
17,153
-9,599
| -36% | -$28.3K | ﹤0.01% | 4378 |
|
|
2025
Q2 | $57.5K | Sell |
26,752
-192
| -0.7% | -$537 | ﹤0.01% | 4165 |
|
|
2025
Q1 | $118K | Sell |
26,944
-20,670
| -43% | -$93.2K | ﹤0.01% | 4001 |
|
|
2024
Q4 | $222K | Buy |
+47,614
| New | +$320K | ﹤0.01% | 4038 |
|
|
2020
Q4 | – | Sell |
-2,424
| Closed | -$250K | – | 3874 |
|
|
2020
Q3 | $250K | Buy |
+2,424
| New | +$363K | ﹤0.01% | 3531 |
|
|
2020
Q2 | – | Sell |
-6,052
| Closed | -$592K | – | 3956 |
|
|
2020
Q1 | $592K | Sell |
6,052
-13,064
| -68% | -$1.52M | ﹤0.01% | 3117 |
|
|
2019
Q4 | $2.2M | Sell |
19,116
-3,827
| -17% | -$337K | ﹤0.01% | 2384 |
|
|
2019
Q3 | $1.25M | Buy |
22,943
+9,632
| +72% | +$1.09M | ﹤0.01% | 2702 |
|
|
2019
Q2 | $1.58M | Buy |
13,311
+10,721
| +414% | +$887K | ﹤0.01% | 2398 |
|
|
2019
Q1 | $136K | Sell |
2,590
-70
| -3% | -$2.83K | ﹤0.01% | 3449 |
|
|
2018
Q4 | $84K | Sell |
2,660
-3,925
| -60% | -$160K | ﹤0.01% | 3654 |
|
|
2018
Q3 | $398K | Sell |
6,585
-2,160
| -25% | -$121K | ﹤0.01% | 3230 |
|
|
2018
Q2 | $463K | Buy |
8,745
+5,473
| +167% | +$329K | ﹤0.01% | 3160 |
|
|
2018
Q1 | $190K | Buy |
+3,272
| New | +$204K | ﹤0.01% | 3337 |
|
|
2017
Q2 | – | Sell |
-1,832
| Closed | -$49K | – | 3339 |
|
|
2017
Q1 | $49K | Buy |
+1,832
| New | +$52.1K | ﹤0.01% | 3229 |
|
|
2016
Q4 | – | Sell |
-1,415
| Closed | -$58K | – | 3408 |
|
|
2016
Q3 | $58K | Sell |
1,415
-7,706
| -84% | -$292K | ﹤0.01% | 3317 |
|
|
2016
Q2 | $288K | Buy |
+9,121
| New | +$412K | ﹤0.01% | 3033 |
|
|
2015
Q3 | – | Sell |
-1,004
| Closed | -$163K | – | 3698 |
|
|
2015
Q2 | $163K | Buy |
+1,004
| New | +$339K | ﹤0.01% | 3610 |
|
|
2014
Q4 | – | Sell |
-595
| Closed | -$203K | – | 3965 |
|
|
2014
Q3 | $203K | Buy |
+595
| New | +$177K | ﹤0.01% | 3884 |
|
D.E. Shaw & Co's ADVM Position: Q4 2025 in Review
D.E. Shaw & Co sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 17,153 shares — an estimated $77.7K sold.
D.E. Shaw & Co first reported a position in ADVM in Q3 2014 and held it in 19 quarters. The position peaked at $2.2M in Q4 2019. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.
- D.E. Shaw & Co reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
- D.E. Shaw & Co sold 17,153 Adverum Biotechnologies shares in Q4 2025, an estimated $77.7K.
- D.E. Shaw & Co first reported a position in Adverum Biotechnologies in Q3 2014 and held it in 19 quarters.
- D.E. Shaw & Co's Adverum Biotechnologies position peaked at $2.2M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.
Based on D.E. Shaw & Co's 13F filing for Q4 2025, filed 17 Feb 2026.